Pioglitazone ameliorates hepatic damage in irradiated rats via regulating anti-inflammatory and antifibrogenic signaling pathways.

In conclusion, pioglitazone could serve as a promising therapeutic tool for attenuating radiation-induced liver injury in patients with radiotherapy which might be attributed to its anti-inflammatory and antifibrotic activities.
PMID: 31146611 [PubMed - as supplied by publisher]

Source: Free Radical Research - June 1, 2019 Category: Research Tags: Free Radic Res Source Type: research